Tirzepatide emerges a groundbreaking treatment agent for individuals battling type 2 diabetes. As a dual receptor activator, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic https://phoebehpcs862514.blogdeazar.com/40933792/tirzepatide-a-game-changer-for-type-2-diabetes